Clinical Trial Update: Adherence Trial With MS LifeLines ® Services

View source ↗

Summary

The Adherence Trial With MS LifeLines Services sponsored by EMD Serono has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: EMD Serono | Conditions: Multiple Sclerosis, Relapsing-Remitting | Status: TERMINATED